Navigation Links
Results of the TRIGGER-PCI trial reported at TCT 2011
Date:11/9/2011

SAN FRANCISCO, CA NOVEMBER 9, 2011 A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of cardiac death or myocardial infarction the primary endpoint at six month follow up.

Results of the TRIGGER-PCI (Testing platelet Reactivity In patients underGoing elective stent placement on clopidogrel to Guide alternative thErapy with pRasugrel) trial were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

The risk of ischemic events after percutaneous coronary intervention (PCI) is elevated in patients with high on-clopidogrel platelet reactivity (HCPR). Novel P2Y12-receptor antagonists, such as prasugrel, are more potent than clopidogrel and may, thus, improve outcome with respect to ischemic events, but may also increase bleeding risk.

The trial was a multi-center, double-blind, randomized controlled trial. Platelet reactivity was assessed two to seven hours after the first maintenance dose of clopidogrel 75 mg on the day after PCI following loading with clopidogrel 600 mg and randomized to either prasugrel or clopidogrel. TRIGGER-PCI aimed to randomize 2,150 patients to have a 93% power for detecting a 50% relative risk reduction on prasugrel in the primary study endpoint (cardiovascular death or myocardial infarction within six months).

The study was terminated prematurely for futility at March 18, 2011 at which 236 patients completed the six-month follow up. Only one clinical endpoint, a peri-procedural myocardial infarction, was observed.

"High on-clopidogrel platelet reactivity (>208 PRU by VerifyNow P2Y12 test) was observed less frequently than expected," said Dietmar Trenk PhD. Dr. Trenk is Professor and Head of Clinical Pharmacology at Herz-
'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results
2. SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call
3. Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results
4. First blinded study of venous insufficiency prevalence in MS shows promising results
5. NEJM Publishes Trial Results Demonstrating Bard FLAIR Endovascular Stent Graft Is Superior To Balloon Angioplasty For Failing Dialysis Grafts
6. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
7. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
8. United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results
9. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
10. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
11. WebMD Announces Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, 2014 (HealthDay ... -- as mandated under the Affordable Care Act -- could ... deny insurance coverage for any medical practice that violates their ... experts counter that such predictions are unlikely to come true. ... Stores Inc. and Conestoga Wood Specialties Corp. did not have ...
(Date:7/28/2014)... 28, 2014 This is a ... Chinese Tadalafil industry. The report firstly reviews the ... and manufacturing technology. The report then explores global ... product specification, capacity, Production value, and market share ... global and China’s total market of Tadalafil by ...
(Date:7/28/2014)... Carolina (PRWEB) July 28, 2014 The ... their first bite of food best, with each subsequent ... the researchers found, can actually serve to sabotage the ... in foods they enjoy, not realizing the effect," Baba ... is the argument for moderation, if we needed one. ...
(Date:7/28/2014)... July 28, 2014 H2T Elite Dryland Training ... Located at 573 Alness Street in Toronto, H2T ... of Steeles. H2T is a state of the art facility ... seniors. There are many gyms out there for people 18 ... seniors alone. H2T will be home to many elite athletes ...
(Date:7/28/2014)... Sussex, Wisconsin (PRWEB) July 28, 2014 ... to help First Lady Michelle Obama and Partnership for ... new organizations as they join the group's DrinkUP ... drink more water, more often. , The seven ... Haws Corporation™, Nalgene® Outdoor Products, S’well Bottle, Santa Clara ...
Breaking Medicine News(10 mins):Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 4Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 5Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:Global and Chinese Tadalafil Industry 2009-2019 Market Research Report Now Available at LifeScienceIndustryResearch.com 4Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:FS Local Community Member H2T Elite Dryland Training Is Set to Open Its Doors 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 2Health News:CannedWater4Kids (CW4K) Among Those Invited to the White House to Support First Lady Michelle Obama in Welcoming Seven New Organizations to DrinkUP 3
... EAST RUTHERFORD, N.J., June 4 Cambrex Corporation (NYSE: ... from the New York Stock Exchange ("NYSE") informing the Company ... listing standards. As announced by the Company on April ... continued listing standards because its average market capitalization over a ...
... 4 NxStage Medical, Inc. (Nasdaq: NXTM ), ... Jeffrey H. Burbank, Chief Executive Officer, will be presenting at ... 2009 at The Four Seasons Hotel in Chicago, IL. ... June 9th at 4:30 p.m. (CST). To listen to ...
... potentially deadly conditions , THURSDAY, June 4 (HealthDay News) ... and forms a scab after a cut? Researchers have ... , "The human body has an incredible ability to ... P. Wong, a principal investigator at the Rowland Institute ...
... Latino Pennsylvanians , , HARRISBURG, Pa., June 4 ... of Estoydecidido.com , a resource tool to help ... Estoydecidido.com -- which translates to "I am determined" ... DeterminedToQuit.com site. , , "Latinos have become ...
... Laboratories, Inc., a leading research-based contract manufacturer of intermediates, ... pleased to announce the issuance by the Tianjin branch ... a manufacturing certificate for drug products to our Tianjin ... dosage forms including tablets, capsules, and pellets. , ...
... , , CLEVELAND, June 4 In ... of six selected to the International Factoring Association Advisory Board. ... Cohen will be asked to provide guidance and feedback to ... board members, Mr. Cohen will also be responsible for communicating ...
Cached Medicine News:Health News:NxStage to Present at the William Blair Growth Stock Conference 2Health News:Researchers Detect Blood-Clotting Mechanism 2Health News:Pennsylvania Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Asymchem Announces sFDA Certification for Drug Product Manufacturing 2Health News:President of PRN Funding Appointed to Factoring Association Advisory Board 2
(Date:7/28/2014)... INCLINE VILLAGE, Nev. , July 28, 2014 ... announced that the Company will release its second quarter 2014 ... Monday, August 11, 2014, after market close. PDL,s management will ... p.m. Eastern Time to discuss the financial results.  A slide ... webcast link on the PDL website. Conference Call ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
(Date:7/25/2014)... HILL, N.C. , July 25, 2014  Corporate ... challenges, including understanding new advancements in technology and how ... of this, libraries in the pharmaceutical and medical device ... value of the information and services they provide. ... Best Practices, LLC there are many forces of change ...
Breaking Medicine Technology:PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6Forces of Change Reshaping Corporate Libraries & Information Services 2
... on 01/05/2012 of Santa Barbara physician Dr. Julio Diaz ... overdose deaths from prescription medications. According to one of ... centers, Dr. Diaz,s arrest points to the dangers both ... of finding a physician who will prescribe medication for ...
... PHILADELPHIA, January 10, 2012 Shire plc (LSE: ... company, announced today that it has acquired the rights to ... States (US) in an agreement  with Janssen Pharmaceutica N.V.  Terms ... a prokinetic, is part of Shire,s gastrointestinal (GI) portfolio in ...
Cached Medicine Technology:Arrest of California Doctor Coincides with Uptick in Prescription Drug Overdoses 2Shire Acquires US Rights to Resolor® (prucalopride) 2Shire Acquires US Rights to Resolor® (prucalopride) 3Shire Acquires US Rights to Resolor® (prucalopride) 4
... TCS Symphony orchestrates images and patient ... and information sources in one central ... workflow and improves cost-effectiveness so that ... they do best, helping people., ,Many ...
... Bright quartz halogen illumination with ... filter for whiter light Worldwide ... controlled fan keeps unit coo. ... change Optional tray will clamp ...
... Lite positions directly over one,eye permitting ... lens an exclusive feature ,resulting ... optic light that penetrates,deep into a ... swivel mount enables the,surgeon to rotate ...
Mounted on a remarkably lightweight and,flexible cotton headband with crown strap,the Sport is fully adjustable....
Medicine Products: